BRCA1 and breast cancer: Results from the Danish Breast Cancer Group [20] also confirmed that BRCA mutation was not associated with OS (adjusted HR: 1.98, 95% CI: 0.87–4.52, p = 0.10) while BRCA1 breast cancer patients had shorter ten-year DFS than BRCA2 BC patients.